HCPCS Level II
J0893: Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
A HCPCS Level II code in category J, drugs administered other than oral method.
Source: CMS HCPCS Level II, October 2026 file dated September 23, 2026. Publisher page
Run it in Rivvi
Check every code on your export
Upload a claims or charge export. Rivvi flags HCPCS codes that are deleted or replaced, with the replacement and its date.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Codes near J0893
These sit next to J0893 in the CMS Level II file. All J codes
- J0888Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)
- J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0894Injection, decitabine, 1 mg
- J0895Injection, deferoxamine mesylate, 500 mg
- J0896Injection, luspatercept-aamt, 0.25 mg
- J0897Injection, denosumab, 1 mg
- J0898Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)